ABSTRACT:The pulmonary renin-angiotensin system (RAS) contributes to inflammation and epithelial apoptosis in meconium aspiration. It is unclear if both angiotensin II receptors (ATR) contribute, where they are expressed and if meconium modifies subtype expression. We examined ATR subtypes in 2 wk rabbit pup lungs before and after meconium exposure and with and without captopril pretreatment or type 1 receptor (AT 1 R) inhibition with losartan, determining expression and cellular localization with immunoblots, RT-PCR and immunohistochemistry, respectively. Responses of cultured rat alveolar type II pneumocytes were also examined. Type 2 ATR were undetected in newborn lung before and after meconium instillation. AT 1 R were expressed in pulmonary vascular and bronchial smooth muscle and alveolar and bronchial epithelium. Meconium increased total lung AT 1 R protein approximately 3-fold (p ϭ 0.006), mRNA 29% (p ϭ 0.006) and immunostaining in bronchial and alveolar epithelium and smooth muscle, which were unaffected by captopril and losartan. Meconium also increased AT 1 R expression Ͼ3-fold in cultured type II pneumocytes and caused concentrationdependent cell death inhibited by losartan. Meconium increases AT 1 R expression in newborn rabbit lung and cultured type II pneumocytes and induces AT 1 R-mediated cell death. The pulmonary RAS contributes to the pathogenesis of meconium aspiration through increased receptor expression. T he fetal excretion of meconium into the amniotic fluid occurs in 18 -20% of near-term and term pregnancies and is associated with intra-uterine stress (1-5). When episodes are severe, fetal respiratory efforts are altered and meconium contaminated amniotic fluid may be inhaled before, at the time of, or soon after birth in approximately 5% of neonates. These neonates may develop pneumonitis and lung injury secondary to meconium aspiration syndrome (MAS) (2,3,5,6). Thirty percent of neonates with MAS require mechanical ventilation, and many develop respiratory failure requiring inhaled nitric oxide, high-frequency ventilation, or extracorporal membrane oxygenation. It is unclear, however, what contributes to the pathogenesis and severity of MAS.The clinical manifestations of MAS reflect airway obstruction due to inhaled particulate matter and development of chemical pneumonitis and inflammation, which contribute to the severity of MAS (5). Inflammatory cytokines are elevated in the blood of newborn piglets and the tracheal lavage and lungs of animals after pulmonary instillation of meconium (5,7-10). In most animal studies, homogenized meconium containing particulate matter was instilled into the lungs, making it difficult to separate the obstructive and inflammatory components. We (7) removed the obstructive effects of the particulate matter by using a sterile filtrated supernatant from homogenized term human meconium (MS). In newborn rabbits, MS caused pulmonary inflammation, neutrophil migration, epithelial cell apoptosis, and activation of the pulmonary renin-angiotensin system (RAS) ...